BioLargo (NASDAQ:BLGO – Get Free Report) is one of 33 publicly-traded companies in the “Chemicals & allied products” industry, but how does it compare to its peers? We will compare BioLargo to related businesses based on the strength of its dividends, profitability, risk, analyst recommendations, earnings, institutional ownership and valuation.
Profitability
This table compares BioLargo and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
BioLargo | -16.53% | -58.35% | -32.12% |
BioLargo Competitors | -568.74% | 5.73% | -0.15% |
Earnings and Valuation
This table compares BioLargo and its peers gross revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
BioLargo | $12.23 million | -$3.50 million | -8.03 |
BioLargo Competitors | $6.87 billion | $214.06 million | 66.02 |
Analyst Ratings
This is a summary of recent recommendations and price targets for BioLargo and its peers, as reported by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
BioLargo | 0 | 0 | 0 | 0 | N/A |
BioLargo Competitors | 139 | 1282 | 1594 | 46 | 2.51 |
As a group, “Chemicals & allied products” companies have a potential upside of 6.77%. Given BioLargo’s peers higher possible upside, analysts plainly believe BioLargo has less favorable growth aspects than its peers.
Risk & Volatility
BioLargo has a beta of 0.18, suggesting that its stock price is 82% less volatile than the S&P 500. Comparatively, BioLargo’s peers have a beta of 1.83, suggesting that their average stock price is 83% more volatile than the S&P 500.
Institutional and Insider Ownership
0.0% of BioLargo shares are owned by institutional investors. Comparatively, 71.1% of shares of all “Chemicals & allied products” companies are owned by institutional investors. 20.3% of BioLargo shares are owned by company insiders. Comparatively, 9.5% of shares of all “Chemicals & allied products” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Summary
BioLargo peers beat BioLargo on 8 of the 10 factors compared.
About BioLargo
BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
Receive News & Ratings for BioLargo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLargo and related companies with MarketBeat.com's FREE daily email newsletter.